12:00 AM
May 28, 2012
 |  BioCentury  |  Finance

AbbVie earlier

Abbott Biotech Ventures will go with AbbVie newco; invest earlier
AbbVie earlier

Early stage investorAbbott Biotech Ventures will start investing even earlier after parent company Abbott Laboratories (NYSE:ABT) splits in two, the firm's head of venture investment, Steven Kuemmerle, said at last week's C21 BioVentures conference in Napa, Calif.

Abbott Biotech Ventures will be part of AbbVie, a research-based pharmaceutical company. The other public company will house Abbott's generics, devices, diagnostic and nutritional businesses and retain Abbott's name. The split is expected...

Read the full 345 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >